Cargando…
Theophylline is able to partially revert cachexia in tumour-bearing rats
BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submit...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495887/ https://www.ncbi.nlm.nih.gov/pubmed/22909172 http://dx.doi.org/10.1186/1743-7075-9-76 |
_version_ | 1782249585040687104 |
---|---|
author | Olivan, Mireia Springer, Jochen Busquets, Sílvia Tschirner, Anika Figueras, Maite Toledo, Miriam Fontes-Oliveira, Cibely Genovese, Maria Inés Ventura da Silva, Paula Sette, Angelica López-Soriano, Francisco J Anker, Stefan Argilés, Josep M |
author_facet | Olivan, Mireia Springer, Jochen Busquets, Sílvia Tschirner, Anika Figueras, Maite Toledo, Miriam Fontes-Oliveira, Cibely Genovese, Maria Inés Ventura da Silva, Paula Sette, Angelica López-Soriano, Francisco J Anker, Stefan Argilés, Josep M |
author_sort | Olivan, Mireia |
collection | PubMed |
description | BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. RESULTS: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. CONCLUSION: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia. |
format | Online Article Text |
id | pubmed-3495887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34958872012-11-13 Theophylline is able to partially revert cachexia in tumour-bearing rats Olivan, Mireia Springer, Jochen Busquets, Sílvia Tschirner, Anika Figueras, Maite Toledo, Miriam Fontes-Oliveira, Cibely Genovese, Maria Inés Ventura da Silva, Paula Sette, Angelica López-Soriano, Francisco J Anker, Stefan Argilés, Josep M Nutr Metab (Lond) Research BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. RESULTS: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. CONCLUSION: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia. BioMed Central 2012-08-21 /pmc/articles/PMC3495887/ /pubmed/22909172 http://dx.doi.org/10.1186/1743-7075-9-76 Text en Copyright ©2012 Olivan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Olivan, Mireia Springer, Jochen Busquets, Sílvia Tschirner, Anika Figueras, Maite Toledo, Miriam Fontes-Oliveira, Cibely Genovese, Maria Inés Ventura da Silva, Paula Sette, Angelica López-Soriano, Francisco J Anker, Stefan Argilés, Josep M Theophylline is able to partially revert cachexia in tumour-bearing rats |
title | Theophylline is able to partially revert cachexia in tumour-bearing rats |
title_full | Theophylline is able to partially revert cachexia in tumour-bearing rats |
title_fullStr | Theophylline is able to partially revert cachexia in tumour-bearing rats |
title_full_unstemmed | Theophylline is able to partially revert cachexia in tumour-bearing rats |
title_short | Theophylline is able to partially revert cachexia in tumour-bearing rats |
title_sort | theophylline is able to partially revert cachexia in tumour-bearing rats |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495887/ https://www.ncbi.nlm.nih.gov/pubmed/22909172 http://dx.doi.org/10.1186/1743-7075-9-76 |
work_keys_str_mv | AT olivanmireia theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT springerjochen theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT busquetssilvia theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT tschirneranika theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT figuerasmaite theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT toledomiriam theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT fontesoliveiracibely theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT genovesemariaines theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT venturadasilvapaula theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT setteangelica theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT lopezsorianofranciscoj theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT ankerstefan theophyllineisabletopartiallyrevertcachexiaintumourbearingrats AT argilesjosepm theophyllineisabletopartiallyrevertcachexiaintumourbearingrats |